UPDATED Jul 06, 2022
Discover large cap U.K. Pharmaceuticals & Biotech companies that are on the FTSE. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| AZNAstraZeneca | UKĀ£109.78 | -0.7% | 26.8% | UKĀ£170.1b | UKĀ£117.56 | PS4.9x | E27.5% | 1.9% | ||
| GSKGSK | UKĀ£17.90 | -0.2% | 24.6% | UKĀ£90.6b | UKĀ£18.69 | PE17.7x | E10.4% | 4.5% | ||
| DPHDechra Pharmaceuticals | UKĀ£37.32 | 7.7% | -18.2% | UKĀ£4.0b | UKĀ£47.33 | PE55.5x | E9.7% | 1.1% | ||
| HIKHikma Pharmaceuticals | UKĀ£16.83 | 2.2% | -34.7% | UKĀ£3.7b | UKĀ£25.62 | PE10.5x | E3.4% | 2.7% | ||
| ABCAbcam | UKĀ£12.58 | 6.4% | -10.1% | UKĀ£2.9b | UKĀ£15.03 | PE653.8x | E35.7% | 0% | ||
| ONTOxford Nanopore Technologies | UKĀ£3.10 | 5.6% | n/a | UKĀ£2.6b | UKĀ£5.80 | PS19.1x | E33.9% | n/a | ||
| INDVIndivior | UKĀ£3.06 | -1.5% | 91.4% | UKĀ£2.1b | UKĀ£3.76 | PE15.3x | E11.6% | 0% | ||
| HCMHUTCHMED (China) | UKĀ£2.37 | 12.1% | -55.3% | UKĀ£2.0b | UKĀ£3.55 | PS6.8x | E25.7% | n/a | ||
| GNSGenus | UKĀ£26.56 | 8.9% | -47.9% | UKĀ£1.7b | UKĀ£46.05 | PE46.8x | E18.6% | 1.1% | ||
| APHAlliance Pharma | UKĀ£1.16 | 2.8% | 14.6% | UKĀ£626.1m | UKĀ£1.38 | PE85.5x | E21.0% | 1.5% | ||
| ERGOErgomed | UKĀ£10.50 | 5.0% | -12.5% | UKĀ£523.7m | UKĀ£14.17 | PE41.3x | E15.6% | n/a | ||
| PRTCPureTech Health | UKĀ£1.78 | 5.8% | -47.7% | UKĀ£509.9m | UKĀ£6.72 | PS34.9x | E-16.4% | n/a | ||
| OXBOxford Biomedica | UKĀ£4.81 | 4.6% | -64.9% | UKĀ£462.1m | UKĀ£13.41 | PE24.3x | E-29.3% | n/a | ||
| MXCTMaxCyte | UKĀ£3.90 | -4.9% | -61.8% | UKĀ£396.3m | UKĀ£10.97 | PS12.1x | E7.3% | n/a | ||
| AVCTAvacta Group | UKĀ£1.02 | -6.7% | -36.4% | UKĀ£254.3m | UKĀ£1.87 | PS86.6x | E1.9% | n/a | ||
| REDXRedx Pharma | UKĀ£0.68 | 1.5% | 21.4% | UKĀ£226.7m | UKĀ£1.54 | PS13.9x | E-11.0% | n/a | ||
| BVXPBioventix | UKĀ£34.00 | -2.9% | -12.8% | UKĀ£177.1m | UKĀ£43.00 | PE26.8x | E0.04% | 4.2% | ||
| ANCRAnimalcare Group | UKĀ£2.67 | -2.9% | -25.0% | UKĀ£160.4m | UKĀ£4.49 | PS2.2x | S3.2% | 1.8% | ||
| CIRCircassia Group | UKĀ£0.32 | -2.4% | 7.7% | UKĀ£135.0m | n/a | PE58.8x | E32.6% | n/a | ||
| SARSareum Holdings | UKĀ£1.85 | -7.5% | -47.9% | UKĀ£125.9m | n/a | PB22.2x | E-31.4% | n/a | ||
| AGYAllergy Therapeutics | UKĀ£0.19 | -8.4% | -24.8% | UKĀ£122.4m | n/a | PS1.5x | E-11.4% | n/a | ||
| FARNFaron Pharmaceuticals Oy | UKĀ£2.10 | -2.3% | -44.4% | UKĀ£116.1m | UKĀ£4.41 | PB46.5x | E-0.001% | n/a | ||
| SCLPScancell Holdings | UKĀ£0.13 | -1.9% | -42.0% | UKĀ£105.0m | n/a | PB4.6x | E-51.7% | n/a | ||
| ARECArecor Therapeutics | UKĀ£3.25 | -3.0% | 36.6% | UKĀ£90.5m | UKĀ£5.28 | PS78.1x | E22.8% | n/a |